D

Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager
Devyser Diagnostics AB
STO:DVYSR
Watchlist
Price: 119 SEK 3.48% Market Closed
Market Cap: 2B SEK
Have any thoughts about
Devyser Diagnostics AB?
Write Note

Devyser Diagnostics AB
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Devyser Diagnostics AB
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
D
Devyser Diagnostics AB
STO:DVYSR
Total Current Assets
kr341.8m
CAGR 3-Years
105%
CAGR 5-Years
65%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Total Current Assets
kr1.9B
CAGR 3-Years
4%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Total Current Assets
kr511.9m
CAGR 3-Years
17%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Total Current Assets
kr2.1B
CAGR 3-Years
-26%
CAGR 5-Years
15%
CAGR 10-Years
23%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Total Current Assets
kr12.6B
CAGR 3-Years
20%
CAGR 5-Years
18%
CAGR 10-Years
21%
BioArctic AB
STO:BIOA B
Total Current Assets
kr1.2B
CAGR 3-Years
5%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
No Stocks Found

Devyser Diagnostics AB
Glance View

Market Cap
2B SEK
Industry
Biotechnology

Devyser Diagnostics AB engages in the development, manufacture and sale of kits for genetic testing in routine diagnostics. The company is headquartered in Hagersten, Stockholm. The company went IPO on 2021-12-10. The products are used for complex deoxyribonucleic acid (DNA) testing in the areas of hereditary diseases, oncology, and post-transplantation monitoring in order to diagnose genetic diseases and target cancer treatment. The firm has since its inception developed and launched almost 30 products for routine diagnostic use, including Devyser Thrombophilia assay as well as Devyser Resolution XY for analysis of chromosomes X and Y. Devyser Diagnostics’ products are sold directly to the end customer or through hired distributors. The firm provides its products in more than 45 countries.

DVYSR Intrinsic Value
118.6 SEK
Fairly Valued
Intrinsic Value
Price
D

See Also

What is Devyser Diagnostics AB's Total Current Assets?
Total Current Assets
341.8m SEK

Based on the financial report for Dec 31, 2023, Devyser Diagnostics AB's Total Current Assets amounts to 341.8m SEK.

What is Devyser Diagnostics AB's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
65%

Over the last year, the Total Current Assets growth was -17%. The average annual Total Current Assets growth rates for Devyser Diagnostics AB have been 105% over the past three years , 65% over the past five years .

Back to Top